Literature DB >> 9732909

Risk of atrioventricular block during adenosine pharmacologic stress testing in heart transplant recipients.

J Toft1, J Mortensen, B Hesse.   

Abstract

Pharmacologic stress testing with adenosine in heart transplant recipients implies a high risk of atrioventricular block. Dipyridamole is preferable as a coronary vasodilator.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9732909     DOI： 10.1016/s0002-9149(98)00392-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Sinus arrest during adenosine stress testing in liver transplant recipients with graft failure: three case reports and a review of the literature.

Authors:  Kenneth N Giedd; Sabahat Bokhari; Teresa P Daniele; Lynne L Johnson
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

2.  Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients.

Authors:  João L Cavalcante; Joaquim Barboza; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2011-05-28       Impact factor: 5.952

3.  Safety of adenosine pharmacologic stress myocardial perfusion imaging in orthotopic cardiac transplant recipients: a single center experience of 102 transplant patients.

Authors:  Mouaz H Al-Mallah; Muhammad Arida; Enrique Garcia-Sayan; Chafik Assal; Gino Tapia Zegarra; Barbara Czerska; Karthik Ananthasubramaniam
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-19       Impact factor: 2.357

4.  Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation.

Authors:  Jonathan N Flyer; Warren A Zuckerman; Marc E Richmond; Brett R Anderson; Tamar G Mendelsberg; Jennie M McAllister; Leonardo Liberman; Linda J Addonizio; Eric S Silver
Journal:  Circulation       Date:  2017-04-27       Impact factor: 29.690
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.